J
02179
Jiangsu Recbio Technology
5.72
1.56+37.50%Closed16:08 01/13 HKT
OPEN/PREV CLOSE4.480/4.160
TODAY RANGE4.480-6.700
VOL293.50K
MARKET CAP3.58B
52 WEEK RANGE3.400-9.800
AVG VOL (3M)56.42K
% TURNOVER0.05%
TURNOVER1.74M
P/E (TTM)-4.994
% RANGE53.37%
EPS(TTM)-1.145
P/E(FORWARD)-6.644
P/B18.386
BVPS0.311
DIVIDEND--
P/S149.738
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.81B
SHARES OUTSTANDING626.08M
NEXT EARNINGS--
FREE FLOAT316.14M
LOT SIZE500
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
Haoyu Xu Spends CN¥1.7m Buying Jiangsu Recbio Technology Shares
Reuters·12/29/2025 14:45
China Accepts New Drug Application for Recbio's Recombinant Shingles Vaccine
Simply Wall St·12/24/2025 00:51
Insiders' CN¥12.4m Investments In Red Following Jiangsu Recbio Technology's HK$341m Dip In Market Value
Reuters·12/23/2025 11:47
Jiangsu Recbio Files Director List with HKEX
Reuters·12/23/2025 11:41
Jiangsu Recbio Appoints Xu Haoyu as Chairman After Liu Yong Resigns
Reuters·12/19/2025 14:34
Jiangsu Recbio Files Directors List with HKEX
Reuters·12/19/2025 14:29
Jiangsu Recbio Technology Co. Ltd. Held Extraordinary General Meeting
Reuters·12/01/2025 14:50
Jiangsu Recbio Technology Co. Ltd. Announces Date for First Extraordinary General Meeting
Reuters·12/01/2025 14:10
Jiangsu Recbio Files Director List with HKEX
Reuters·11/14/2025 10:51
Jiangsu Recbio Receives Approval for Expanded Production of Recombinant Shingles Vaccine
Simply Wall St·11/12/2025 02:29
Jiangsu Recbio Technology Co., Ltd.'s (HKG:2179) market cap dropped HK$398m last week; Retail investors bore the brunt
Reuters·08/29/2025 11:02
JIANGSU RECBIO TECHNOLOGY H1 CAPEX RMB 55.4 MILLION
Simply Wall St·04/29/2025 22:24
Here's Why Jiangsu Recbio Technology (HKG:2179) Can Afford Some Debt
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email : service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.